Loading clinical trials...

CompaRison of Paresthesia Mapping to anatomIc Midline-based burSt Programming Strategies | Clinical Trials | Clareo Health

COMPLETEDNA

CompaRison of Paresthesia Mapping to anatomIc Midline-based burSt Programming Strategies

NCT02986074•Abbott Medical Devices

View on ClinicalTrials.gov

Summary

The study will compare therapeutic efficacy of a novel spinal cord stimulation leads implant based on anatomical landmarks with standard surgical implantation technique.

Detailed Description

The primary purpose of this study is to compare the therapeutic efficacy of the conventional, paresthesia mapping-based burst spinal cord stimulation (SCS) implantation strategy to a more novel, anatomic midline-based approach that has the potential to streamline the workflow associated with the SCS treatment continuum.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Subject is able to provide informed consent to participate in the study;
•Subject is 18 years of age or older;
•Subject has failed to respond to at least 6 months of conventional treatment including pharmacological treatment, physical therapy, epidural injections and/or radiofrequency therapy as per NICE Tag 0159;
•FBSS subjects with predominant low back pain;
•Subject has a lower back pain intensity of at least 6.0 out of 10.0 on the VAS at baseline;
•Subject is on stable pain medications with a total opioid equivalent of 120 mgs a day or less for at least 28 days prior to enrolling in this study, and is willing to stay on those medications with no dose adjustments until activation of the permanently implanted SCS device;
•Subject's medical record has been evaluated by the Investigator to ensure that the subject is a good candidate for a neurostimulation system;
•Subject is willing to cooperate with the study requirements including compliance with the regimen and completion of all office visits;
•Female candidates of child-bearing potential agree to commit to the use of an effective method of contraception (including but not limited to sterilization, barrier devices, oral contraceptives, intrauterine devices (IUDs), condoms, rhythm method, or abstinence) for the duration of the study

Exclusion Criteria

•Subjects with significant scoliosis even if surgically corrected
•Subject is currently participating in a clinical investigation that includes an active treatment arm;
•Subject has been implanted with or participated in a trial period for a neurostimulation system;
•Subject has an infusion pump;
•Subject has evidence of an active disruptive psychological or psychiatric disorder as determined as per standard of care;
•Subject has a current diagnosis of a coagulation disorder, bleeding diathesis, progressive peripheral vascular disease or uncontrolled diabetes mellitus;
•Subject has a current diagnosis of a progressive neurological disease as determined by the Investigator;
•Subject is immunocompromised;
•Subject has an existing medical condition that is likely to require repetitive MRI evaluation in the future (i.e. epilepsy, stroke, multiple sclerosis, acoustic neuroma, tumor);
•Subject has history of cancer requiring active treatment in the last 12 months;
+4 more criteria

Locations (2)

Seacroft Hospital

Leeds, Yorkshire and the Humber, United Kingdom

St. Thomas Hospital

London, United Kingdom

Key Dates

Start Date

November 1, 2016

Primary Completion Date

August 19, 2019

Completion Date

August 19, 2019

Last Updated

May 3, 2021

Enrollment

ACTUAL participants

Conditions

Chronic Pain

Interventions

Paresthesia mapping lead evaluation first

DEVICE

Anatomical midline lead evaluation first

DEVICE

Optimization of NIBS for Treatment of Addiction

NCT04379115

Opioid-use DisorderChronic Pain

View study

RECRUITINGNA

VR Mindfulness Training for Veterans With SCI

NCT06587607

Spinal Cord InjuryChronic Pain

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 3, 2021Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

CompaRison of Paresthesia Mapping to anatomIc Midline-based burSt Programming Strategies

Inclusion Criteria

Exclusion Criteria

Optimization of NIBS for Treatment of Addiction

VR Mindfulness Training for Veterans With SCI

CIH Stepped Care for Co-occurring Chronic Pain and PTSD

Personalized High-Definition tDCS Protocols for Chronic Pain Treatment

Osteopathic Manual Therapy vs Ganglion Impar Block for Chronic Coccydynia

A Mobile Intervention to Reduce Pain and Improve Health-III